Keith Vendola, Md, Mba Email and Phone Number
Keith Vendola, Md, Mba work email
- Valid
- Valid
- Valid
- Valid
Keith Vendola, Md, Mba personal email
Keith Vendola, Md, Mba phone numbers
Summary: As a seasoned biotech CFO with >3 decades experience in healthcare corporate finance including foundations from psychology, medical and business schools, research labs, and Wall Street, Dr. Vendola focuses on building teams and life sciences companies whose missions aim to improve both patient outcomes and investor returns. Passions:Dr. Vendola enjoys leading strong teams, scaling operations, and navigating all types of transactions, including IPOs, financings, and strategic deals, while thoughtfully interacting with physicians, scientists, patients, academics, executives, consultants, accountants, bankers, lawyers, investors, and other stakeholders.Background:Dr. Vendola has served as a Silicon Valley-based public and private company Chief Financial Officer (CFO), Chief Strategy Officer (CSO), Adviser, and Executive and NYC-based bulge bracket Investment Banker (BofA, JPMorgan). Dr. Vendola earned his MBA in Finance from Northwestern’s Kellogg School of Management, MD from Dartmouth Medical School, Research Fellowship in Endocrinology from the NIH, where he authored several papers, and BA in Psychology from Holy Cross, where he graduated with honors.Skills:* Solid network across top investment banks, law firms, accountancies, and funds. * Investor relations and corporate communications. * Strategic leadership including >50 deals across the globe.* Operational planning and execution.* Team building driven by a firm belief in the excellence of others, value of camaraderie, and potential of partnership.Accomplishments:> 500 live investor meetings & multiple presentations.> $2B in successfully executed transactions.> $1B raised capital via IPOs, FPOs, PIPEs, etc. Equity / debt, private / public. > $1B transaction value via M&A, partnerships, and special situations. > $400M managed as CFO across public and private P&Ls.Personal:Avid downhill skier. Adoring husband. Proud father of 3.
Wugen
View-
Chief Financial OfficerWugen 2023 - PresentSt. Louis, Missouri, UsWugen is a clinical-stage private biotech and an industry leader in off-the-shelf allogeneic cell therapies. Backed by top investors, we are developing a CD7 directed CAR-T cell therapy. With promising clinical data, the late stage program addresses a large unmet need in T-ALL/LBL and other indications. As CFO, focus is on strategically growing the business, interacting thoughtfully with investors and other stakeholders, and leading a strong finance team.
-
Chief Financial OfficerIo Biotech 2021 - 2022Copenhagen, Denmark, DkIPOCompany successfully taken public on Nasdaq (IOBT). Peak Mrk Cap while there >$400M. Raised ~$200M. Clinical-stage biotech: immuno-oncology. Launched onto Nasdaq, navigated public markets, scaled team, and executed deals while overseeing FP&A, accounting, treasury, IT, investor relations, corporate communications, etc. Responsibilities: Transactions, Financial Operations, IR and Corp. Comms.* Led $115M IPO & Nasdaq listing (Morgan Stanley, Cowen, Jefferies).* Raised $84M private / crossover round.* Closed 2 Merck collaborations providing pembrolizumab for Ph 3 and Ph 2 trials.* Built and led international teams across FP&A, accounting, treasury, IT, etc. -
Co-Founder And Board MemberRezolute (Bio) Ireland Limited 2019 - 2021
-
Chief Financial Officer & Chief Strategy OfficerRezolute, Inc. 2018 - 2021Redwood City, California, UsUplisting w/ PIPECompany successfully taken public on Nasdaq (RZLT). Peak Mrk Cap >$300M. Raised >$100M. Clinical-stage biotech: orphan and metabolic. Launched onto Nasdaq, navigated public markets, scaled team, and executed deals while overseeing FP&A, accounting, treasury, IT, investor relations, corporate communications, etc. Responsibilities: Financial Operations, Transactions, IR and Corp. Comms.* Led $41M PIPE (Federated, BVF) & Nasdaq listing (CG, JMP, Griffin).* Raised $49M strategic financing (CG, JMP).* Led $50M ATM (Opco), $200M Shelf, and $30M venture debt.* Drove partnership with Xoma. -
Chief Of Staff To Ceo & Vp Of Investor RelationsCoherus Biosciences 2015 - 2017Redwood City, Ca, UsIPOCompany successfully taken public on Nasdaq (CHRS). Peak Mrk Cap while there >$1B. Raised $300M. Commercial-stage biotech / medtech: biosimilars and oncology. Navigated public markets, scaled team, led competitive strategy, and executed deals. Responsibilities: Strategy, Transactions, Special Situations, IR, and Corp. Comms.* Led $100M private placement, sr. convert. notes (HCRP, KKR).* Drove $72M FPO (Barclays underwritten).* Raised $128M FPO (JPMorgan, Citi, Cowen, BMO). -
Management Consultant, Healthcare StrategyBooz & Company. 2013 - 2014Worked with boards and senior executives on strategy, execution, and M&A across healthcare verticals.* Advised large cap pharma (top line >$15B) on strategic direction for flagship asset (>$10B in sales).* Advised public biotech / med tech on go / no-go decision for international JV.* Advised health plan on successful $1.2B acquisition of managed care co.* Advised hospital system with >$10B in revenue on productivity initiatives. -
SabbaticalFamily 2012 - 2012Full-time husband and father. Recreational downhill skier.
-
Co-Founder And Financial Officer, Vp Of Finance & Corporate DevelopmentEiger Biopharmaceuticals 2009 - 2011Reverse merger w/ private roundCompany successfully taken public on Nasdaq (EIGR). Peak Mrk Cap >$400M. Commercial-stage biotech: orphan and infective. Launched company, scaled team, led financial operations, and executed deals. Responsibilities: Financial Operations and Transactions.* Company formation & Stanford spin-out.* Raised venture financings from Sand Hill Rd.* Acquired PC & clinical assets from Stanford, AstraZeneca, and Merck.
-
Head Of Corporate DevelopmentDiobex 2007 - 2009Clinical-stage biotech / medtech: metabolic.
-
Head Of Business DevelopmentThreshold Pharmaceuticals 2004 - 2007IPO and then mergerCompany successfully taken public on Nasdaq (THLD) and later merged into Molecular Templates (MTEM). Peak Mrk Cap while there >$500M. Raised >$100M. Clinical-stage biotech: urology and oncology. Led WW partnering for late stage pipeline. Sourced and managed relationships across pharma and biotech. Executed M&A. Supported financings. Key spokesman at numerous conferences WW.* $37M IPO & Nasdaq listing (BofA, CIBC, Lazard, WB).* $65M FPO (Morgan Stanley, CIBC, Lazard).* Development partnership in Asia.
-
Investment Banker, HealthcareBank Of America 2001 - 2003Charlotte, Nc, UsAdvised on M&A and executed financings that raised ~$450M across healthcare verticals. * $115M IPO and Nasdaq listing for ViaCell, S-1 filed Jan. 2002.* $28M PIPE for Regeneration Technologies.* $115M senior notes offering for Bausch & Lomb.* $125M convertible senior debentures offering for Edwards Lifesciences.* $115M convertible senior debentures offering for Sierra Health Services.* $65M revolving credit facility for Sierra Health Services. -
Investment Banker, HealthcareJpmorgan Chase & Co. 2000 - 2000New York, Ny, Us -
Commercial / MarketingNovartis 1999 - 1999Basel, Baselstadt, Ch
Keith Vendola, Md, Mba Skills
Keith Vendola, Md, Mba Education Details
-
Northwestern University - Kellogg School Of ManagementFinance -
Geisel School Of Medicine At DartmouthMedicine
-
Harvard Business SchoolNegotiations
-
National Institutes Of HealthEndocrinology
-
College Of The Holy CrossPsychology / Pre-Med
Frequently Asked Questions about Keith Vendola, Md, Mba
What company does Keith Vendola, Md, Mba work for?
Keith Vendola, Md, Mba works for Wugen
What is Keith Vendola, Md, Mba's role at the current company?
Keith Vendola, Md, Mba's current role is Biotech CFO - Passionate about the Life Sciences, Building Innovative Companies, & Improving Healthcare for Us All.
What is Keith Vendola, Md, Mba's email address?
Keith Vendola, Md, Mba's email address is kv****@****ech.com
What is Keith Vendola, Md, Mba's direct phone number?
Keith Vendola, Md, Mba's direct phone number is +165057*****
What schools did Keith Vendola, Md, Mba attend?
Keith Vendola, Md, Mba attended Northwestern University - Kellogg School Of Management, Geisel School Of Medicine At Dartmouth, Harvard Business School, National Institutes Of Health, College Of The Holy Cross.
What skills is Keith Vendola, Md, Mba known for?
Keith Vendola, Md, Mba has skills like Mergers And Acquisitions, Strategy, Business Development, Corporate Development, Start Ups, Strategic Planning, Venture Capital, Finance, Financial Modeling, Investment Banking, Valuation, Management Consulting.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial